From: Malignancy validation in a United States registry of rheumatoid arthritis patients
Organ or Type of Malignancy | Physician Form | Records Review – Definite* | Records Review – Probable** | Records Review – Possible*** | Records Review – Not Malignancy or Not An Incident Malignancy**** |
---|---|---|---|---|---|
(Total: 461) | (Total: 234) | (Total: 69) | (Total: 101) | (Total: 57) | |
Skin – NMSC1 | 154 | 71 (46.1%) | 35 (22.7%) | 42 (27.3%) | 6 (3.9%) |
Skin – Melanoma | 9 | 5 (55.6%) | 1 (11.1%) | 2 (22.2%) | 1 (11.1%) |
Skin – Other2 | 5 | 4 (80%) | 1 (20%) | 0 | 0 |
Breast | 59 | 41 (69.5%) | 3 (5.1%) | 13 (22.0%) | 2 (3.4%) |
Hematologic4 | 42 | 32 (76.2%) | 7 (16.7%) | 3 (7.1%) | 0 |
Other3 | 49 | 1 (2.0%) | 0 | 7 (14.3%) | 41 (83.7%) |
Prostate | 38 | 21 (55.3%) | 4 (10.5%) | 11 (29%) | 2 (5.3%) |
Lung | 25 | 11 (44.0%) | 2 (8%) | 9 (36%) | 3 (12%) |
Colon5 | 21 | 13 (61.9%) | 5 (23.8%) | 3 (14.3%) | 0 |
Thyroid | 9 | 3 (33.3%) | 5 (55.5%) | 1 (11.1%) | 0 |
Bladder | 12 | 6 (50%) | 2 (16.7%) | 3 (25%) | 1 (8.3%) |
Head and Neck6 | 7 | 4 (57.1%) | 2 (28.6%) | 1 (14.3%) | 0 |
Uterine | 5 | 3 (60%) | 0 | 1 (20%) | 1 (20%) |
Upper GI7 | 4 | 4 (100%) | 0 | 0 | 0 |
Renal | 4 | 2 (50%) | 1 (25%) | 1 (25%) | 0 |
Cervical | 3 | 1 (33.3%) | 0 | 2 (66.7%) | 0 |
Ovarian | 3 | 2 (66.7%) | 0 | 1 (33.3%) | 0 |
Pancreatic | 2 | 2 (100%) | 0 | 0 | 0 |
Bile duct | 1 | 1 (100%) | 0 | 0 | 0 |
Parotid Gland | 2 | 1 (50%) | 0 | 1 (50%) | 0 |
Brain | 2 | 1 (50%) | 1 (50%) | 0 | 0 |
Hepatic | 2 | 2 (100%) | 0 | 0 | 0 |
Peritoneum | 1 | 1 (100%) | 0 | 0 | 0 |
Gallbladder | 1 | 1 (100%) | 0 | 0 | 0 |
Angiosarcoma | 1 | 1 (100%) | 0 | 0 | 0 |